I46.0
Conditions
Interventions
Group 1: In the control group, standard treatment is carried out in accordance with the applicable ERC guidelines. This includes securing the airway, defibrillation and administering medication. In ad
Sponsors
Universitätsklinikum Heidelberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Out of hospital cardiac arrest VF or pVT or “shockable rhythm” determined by an AED Refractory VF/pVT defined as persistent VF/pVT after three defibrillations First dose of amiodarone (300mg) or lidocaine (100mg) according to current ERC guidelines
Exclusion criteria
Exclusion criteria: DNR/DNI Recurrent cardiac arrest with any-ROSC before 4th shock Stacked Defibrillation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hierarchical testing (1)Successful termination of VF / pVT (2)Survival at 24 hours (3)Survival at 30 days with good neurological outcome (CPC 1-2) | — |
Secondary
| Measure | Time frame |
|---|---|
| CPC 1-2 or mRS =2 at hospital discharge ROSC at hospital admission Overall survival at hospital discharge Overall survival at day 30 Differences in survival between study phases within each cluster Any ROSC during prehospital phase Differences in Joules used Differences in impedance Differences in survival between study sites | — |
Countries
Germany
Contacts
Public ContactStephan Katzenschlager
Universitätsklinikum Heidelberg
Outcome results
None listed